Swedish Firms Pledpharma And RTT Merge To Target Orphan Drug Space

Two Late-Stage Assets For Rare Diseases

 
• By Kevin Grogan
  
Swedish flags
Two Swiss companies form new firm targeting orphan diseases • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip